Page 167 - 80 guidelines for the treatment of malaria_opt

ANNEX 7. Uncomplicated Plasmodium falciparum malaria

14. Grande T et al. A randomised controlled trial to assess the efficacy of dihydroartemisinin-
piperaquine for the treatment of uncomplicated falciparum malaria in Peru. PLoS ONE.
2007, 2:e1101.
15. Ratcliff A et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum
and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet,
2007, 369:757–765.
16. Kamya MR et al. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for
treatment of malaria: a randomized trial. PLoS Clinical Trials, 2007, 2:e20.
17. Yeka A et al. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating
uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS ONE, 2008,
3:e2390.
18. Hasugian AR. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior
efficacy and post treatment prophylaxis against multidrug-resistant Plasmodium falciparum
and Plasmodium vivax malaria. Clinical Infectious Diseases, 2007, 44:1067–1074.

A7

153